India Ranked Among Top AI-Ready Healthcare Markets in APAC

IMT News Desk
IMT News Desk
· 2 min read
India emerges as one of the most AI-ready healthcare markets in the APAC with 78 % consumers using GenAI to better understand diagnoses & treatment

India is emerging as one of the most AI-ready healthcare markets in the Asia-Pacific region, with 78 per cent of consumers using generative AI (GenAI) to better understand diagnoses and treatment options, according to a new report by Bain & Company.

The report from Bain & Company said 73 per cent of Indian consumers use GenAI to prepare for appointments, and 72 per cent use it to navigate the healthcare system, making India stand out as one of the Asia-Pacific region’s most AI-ready healthcare markets.

Gen Z is driving digital health adoption, with 66 per cent of Gen Z respondents using online pharmacies and demonstrating higher engagement with AI-enabled healthcare tools and services.

The report said rising expectations for convenience and coordination are colliding with a stretched clinical workforce in Asia-Pacific healthcare systems, accelerating the shift toward new care models and AI-enabled support.

Consumers in India show particularly strong demand for easier access and responsiveness, with 88 percent of respondents expecting more convenient healthcare experiences and 79 percent expecting phone and messaging accessibility from doctors.

Around 93 percent of Indian respondents wanted a single point of coordination across their healthcare journey, highlighting the need for integrated digital health solutions.

This data demonstrates India’s readiness for AI implementation in healthcare, with high consumer adoption rates and strong demand for digital coordination across the entire healthcare journey.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk